Related Experiment Video
Updated: Dec 21, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Circular RNA hsa_circ_0008285 inhibits colorectal cancer cell proliferation and migration via the miR-382-5p/PTEN
Jianjun Wang1, Juanjuan Luo2, Gan Liu3
1Department of Histology and Embryology, Wannan Medical College, Wuhu, 241002, China.
Abstract:
Abundant evidence has showed that circular RNA (circRNA) plays an important role in cancer. Nonetheless, little is known about the roles and mechanisms of specific circRNAs in different cancer types. Hsa_circ_0008285 (circ_0008285), derived from the coding gene chromodomain y-like protein (CDYL), is upregulated in hepatocellular carcinoma and mantle cell lymphoma. However, we previously found, by analyzing two independent high-throughput sequencing datasets, that it was reduced in colon cancer. In this study, we explored the function and mechanism of circ_0008285 in the progression of colorectal cancer (CRC). First, the downregulated expression of circ_0008285 in CRC tissues and cell lines was confirmed using RT-qPCR analysis. In addition, the expression level of circ_0008285 was inversely correlated with tumor size, lymphatic metastasis, and tumor-node-metastasis (TNM) stage through clinicopathological parameter analysis. Functionally, knockdown of circ_0008285 promoted CRC cell proliferation and migration in vitro. Mechanistically, by using RNA-sequencing, bioinformatics analysis, dual-luciferase reporter assay, and western blotting, we determined that circ_0008285 suppressed the PI3K/AKT pathway via the miR-382-5p/PTEN axis. In conclusion, our data demonstrate a tumor suppressor role for circ_0008285 in CRC and suggest circ_0008285 as a potential target for CRC treatment.
Insights
Circular RNA hsa_circ_0008285 is downregulated in colorectal cancer (CRC), promoting tumor growth. It suppresses the PI3K/AKT pathway via miR-382-5p/PTEN, indicating its potential as a CRC therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are implicated in various cancers, but their specific roles and mechanisms in colorectal cancer (CRC) remain underexplored.
- Hsa_circ_0008285 (circ_0008285), derived from the CDYL gene, shows differential expression in cancers, being upregulated in some but reduced in colon cancer.
Purpose of the Study:
- To investigate the function and molecular mechanism of circ_0008285 in the progression of colorectal cancer (CRC).
- To evaluate circ_0008285 as a potential therapeutic target for CRC.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) to confirm circ_0008285 expression in CRC tissues and cell lines.
- Clinicopathological analysis to correlate circ_0008285 levels with tumor progression.
- In vitro functional assays (e.g., knockdown) to assess effects on CRC cell proliferation and migration.
- RNA-sequencing, bioinformatics, dual-luciferase reporter assays, and western blotting to elucidate the underlying molecular mechanism.
Main Results:
- Circ_0008285 expression was significantly downregulated in CRC tissues and cell lines compared to normal controls.
- Lower circ_0008285 levels correlated inversely with tumor size, lymphatic metastasis, and TNM stage.
- Knockdown of circ_0008285 enhanced CRC cell proliferation and migration in vitro.
- Mechanistically, circ_0008285 was found to suppress the PI3K/AKT signaling pathway through the miR-382-5p/PTEN axis.
Conclusions:
- Circ_0008285 acts as a tumor suppressor in colorectal cancer.
- The findings suggest that circ_0008285 could be a potential diagnostic biomarker and therapeutic target for CRC treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Experimental RNAi
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs

